glp-1 obesity drug news today oct 2025 New weight-loss drugs surge in popularity amid surge in US, worldwide Massachusetts cuts GLP-1 coverage for
Description
In adipose tissue, GIP promotes lipogenesis and fat storage under normal conditions
The extensiveness of their overall health benefits has made them one of the primary therapeutic choices for T2DM patients
It has been hypothesized that SGLT2-I may alter the absorption and excretion of calcium and phosphate, resulting in reductions in bone health
The FDA blames increasing demand as the reason for the shortages
GLP-1 receptor agonists: targeting both hyperglycaemia and disease processes in diabetes
Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults
